Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

290
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
290

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigation on the Cytotoxicity of Hydroxycinnamic and Hydroxybenzoic Acid-Based Natural Antioxidant Conjugated Terpyridine Analogues toward Triple-Negative Breast Cancer.

ACS medicinal chemistry letters·2026
Same author

Skeletal Editing of Isoquinolines Via CN/CC Atom-Pair Swap Enables the Synthesis of 3-Arylthio-2-O-acylated Naphthols and DFT Studies.

Organic letters·2026
Same author

Vitamin D3 and K2-loaded keratin nanoparticles inhibit breast cancer cell growth via MCM-7 downregulation and ROS induction.

International journal of biological macromolecules·2026
Same author

Author Correction: Development of Gold coated calcium peroxide nanoparticles for photothermal ferroptosis against skin cancer and C. albicans.

Communications chemistry·2026
Same author

Multitargeted Anticancer Strategy through DNA Damage and Mitochondrial Collapse by a Ferrocene-Benzimidazolium Salt.

ACS applied bio materials·2026
Same author

Carboxymethyl inulin functionalized gold nanoclusters within a chitosan matrix for biocompatible photothermal and anticancer theranostics.

International journal of biological macromolecules·2026

Related Experiment Video

Updated: Jan 7, 2026

Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation
08:24

Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation

Published on: May 22, 2017

8.7K

Inventive HDL Mimicking Nanoparticles: A Promising Frontier in Cardiovascular Disease Management.

Shivani Ratra1, Sunny Mukherjee1, Sandipan Ray2

  • 1Department of Biomedical Engineering, Indian Institute of Technology Hyderabad, Kandi, 502284, Telangana, India.

Cardiovascular Toxicology
|December 18, 2025
PubMed
Summary

HDL-mimicking nanoparticles (HMNPs) offer new hope for cardiovascular disease by restoring HDL function. Advances in HMNP design show promise, but challenges remain for clinical translation and widespread use.

Keywords:
AtherosclerosisCardiovascular disease managementCholesterol effluxHDL mimicking nanoparticlesNanomedicine

More Related Videos

Formulation and Characterization of Bioactive Agent Containing Nanodisks
07:58

Formulation and Characterization of Bioactive Agent Containing Nanodisks

Published on: March 17, 2023

1.6K
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.4K

Related Experiment Videos

Last Updated: Jan 7, 2026

Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation
08:24

Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation

Published on: May 22, 2017

8.7K
Formulation and Characterization of Bioactive Agent Containing Nanodisks
07:58

Formulation and Characterization of Bioactive Agent Containing Nanodisks

Published on: March 17, 2023

1.6K
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.4K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cardiovascular Research

Background:

  • High-density lipoproteins (HDLs) are crucial for cholesterol transport and vascular health.
  • Cardiovascular disease (CVD) impairs HDL function, necessitating therapeutic alternatives.
  • HDL-mimicking nanoparticles (HMNPs) are engineered to restore or enhance HDL biological functions.

Purpose of the Study:

  • To review recent advances in HDL-mimicking nanoparticle (HMNP) design and applications.
  • To highlight progress in theranostic platforms and computational engineering for HMNPs.
  • To discuss translational challenges and future opportunities for HMNPs in cardiovascular care.

Main Methods:

  • Review of preclinical and clinical studies on HMNPs.
  • Analysis of HMNP design strategies, including theranostic and computational approaches.
  • Discussion of manufacturing, regulatory, and clinical variability challenges.

Main Results:

  • Significant progress in HMNP design for therapeutic and diagnostic purposes.
  • Identification of key translational barriers including manufacturing, regulation, and population variability.
  • Emerging opportunities in multi-target nanoplatforms and computational optimization.

Conclusions:

  • HMNPs demonstrate considerable potential for improving cardiovascular care by integrating therapeutic and imaging capabilities.
  • Overcoming technical and clinical hurdles is essential for validating HMNPs' real-world impact.
  • Further research is needed to fully realize the promise of HMNPs for heart disease treatment.